Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Belfort – page 10

125 clinical trials in Belfort, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Belfort at a glance
125
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

125 trials in Belfort

Open in trial search

Study of Zolbetuximab with Nab-Paclitaxel and Gemcitabine for Adults with Metastatic Pancreatic Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Astellas Pharma Global Development Inc.

Chronic kidney disease+1

Not recruiting

Study on Low Dose Rivaroxaban for Heart and Blood Vessel Disease in Patients with Advanced Kidney Disease or on Dialysis

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rivaroxaban
  • Sponsor:The George Institute For Global Health

Study Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Study on Preserving the Voice Box in Patients with Advanced Laryngeal or Hypopharyngeal Cancer Using Cisplatin, Fluorouracil, and Docetaxel Therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou

Myelofibrosis

Not recruiting

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:Karyopharm Therapeutics Inc.

Study on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Brentuximab Vedotin
  • Sponsor:Seagen Inc.

Study Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive

Lung disorder

Not recruiting

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Oslo University Hospital HF

Study on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique

Diabetic neuropathy

Not recruiting

Study on GSK3858279 for Adults with Chronic Diabetic Nerve Pain

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:GSK3858279
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Head and neck cancer

Not recruiting

Study of Radiotherapy with Cetuximab and Xevinapant for Patients with Advanced Head and Neck Cancer Unfit for High-Dose Cisplatin

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou

Other cities in France

The busiest research cities in the country

All 376 cities in France

Clinical research in Belfort

What the registry says about research in the country

01 Respiratory and Circulatory Physiology

The clinical research activity in Belfort focuses on a small but clearly targeted set of studies within Phenomena and Processes, especially Circulatory and Respiratory Physiological Phenomena. These trials are examining how treatments may improve patient outcomes in serious lung and blood-circulation-related conditions.

  • Research in Chronic pulmonary aspergillosis is assessing better control of persistent fungal lung disease
  • Studies in Septic shock are exploring ways to support critically ill patients with severe circulatory failure
  • Clinical work is aimed at comparing treatment effectiveness and improving patient survival and recovery

This area brings together respiratory and intensive care research, with a focus on evaluating whether new or combined approaches can provide stronger clinical benefit than standard care alone.

02 Pulmonary Infection and Antifungal Care

One line of research is centered on Chronic pulmonary aspergillosis, a long-term fungal infection affecting the lungs. The studies are designed to test whether adding another therapy can improve both clinical response and imaging results in patients with limited immune suppression.

  • Focus on persistent fungal lung infection and treatment response
  • Evaluation of whether combination therapy offers added benefit over standard antifungal care
  • Interest in both symptom improvement and radiological outcomes

These trials help clarify how best to manage a difficult respiratory condition where long-term control is often a challenge.

03 Critical Care and Septic Shock Research

Another study area examines Septic shock in mechanically ventilated patients, with attention on treatments that may improve outcomes in severe, refractory cases. The goal is to see whether an added supportive therapy can reduce mortality alongside standard critical care.

  • Research on severe infection-related shock and organ support
  • Assessment of adjunctive treatment for patients not responding well to usual care
  • Outcome focus on short-term survival in intensive care settings

This work supports efforts to strengthen treatment strategies for one of the most urgent emergencies in intensive care medicine.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.